Cargando…
Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
The goals of drug repositioning are to find a new pharmacological effect of a drug for which human safety and pharmacokinetics are established and to expand the therapeutic range of the drug to another disease. Such drug discovery can be performed at low cost and in the short term based on the resul...
Autores principales: | Banno, Kouji, Iida, Miho, Yanokura, Megumi, Irie, Haruko, Masuda, Kenta, Kobayashi, Yusuke, Tominaga, Eiichiro, Aoki, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334926/ https://www.ncbi.nlm.nih.gov/pubmed/25734181 http://dx.doi.org/10.1155/2015/341362 |
Ejemplares similares
-
MicroRNAS in endometrial cancer: recent advances and potential clinical applications
por: Yanokura, Megumi, et al.
Publicado: (2015) -
Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer
por: UMENE, KIYOKO, et al.
Publicado: (2015) -
Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2018) -
ARID1A gene mutation in ovarian and endometrial cancers (Review)
por: TAKEDA, TAKASHI, et al.
Publicado: (2016) -
Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review)
por: BANNO, KOUJI, et al.
Publicado: (2013)